11 December 2013

Access to affordable drugs for the world's poor will be hampered if a US plan to impose stricter pharmaceutical patents is adopted at talks on a Pacific trade pact, activists say... Trade ministers from 12 countries entered a third day of talks in Singapore yesterday in an attempt to meet a US deadline to reach a deal on the proposed Trans-Pacific Partnership before the year ends... The US pharmaceutical industry is pushing for 12 years of "data protection" for a new class of drugs called biologics, which are developed from living tissues rather than chemicals and are being used to treat illnesses such as cancer and diabetes.

Read article below